3
Announcements
Trials
Browse
Landscape
Phase
Phase 3
2
Status
Completed
12
Recruiting
6
Unknown
4
Not yet recruiting
3
Terminated
2
Active not recruiting
2
Withdrawn
1
Sponsor Class
OTHER
1
INDUSTRY
1
Study Type
Interventional
2
Sponsor
Cancer Type
Genitourinary
1
Gastrointestinal
1
Conditions
Breast Neoplasms
989
Neoplasms
848
Carcinoma, Non-Small-Cell Lung
842
Prostatic Neoplasms
527
Neoplasm Metastasis
500
Leukemia, Myeloid, Acute
488
Melanoma
453
Colorectal Neoplasms
446
Multiple Myeloma
440
Lung Neoplasms
419
Pancreatic Neoplasms
352
Recurrence
350
Lymphoma
349
Ovarian Neoplasms
341
Lymphoma, Non-Hodgkin
327
Leukemia
323
Leukemia, Lymphocytic, Chronic, B-Cell
301
Precursor Cell Lymphoblastic Leukemia-Lymphoma
271
Carcinoma, Renal Cell
256
Head and Neck Neoplasms
246
Brain Neoplasms
243
Carcinoma, Hepatocellular
234
Squamous Cell Carcinoma of Head and Neck
231
Glioblastoma
231
Myelodysplastic Syndromes
229
Lymphoma, Large B-Cell, Diffuse
228
Lymphoma, Follicular
219
Colonic Neoplasms
191
Stomach Neoplasms
182
Rectal Neoplasms
175
Interventions
Oxaliplatin
1
Mitomycin
1
Gemcitabine
1
Ethiodized Oil
1
Cisplatin
1
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
2 trials
Recent
Start date
Enrollment
Terminated
×
Interventional
×
Neoplasm Recurrence, Local
×
Clear all
NCT01200992
2017-08-24
EMBARC-RF
Bioniche Life Sciences Inc.
Phase 3
Terminated
84 enrolled
7 charts
NCT00470340
2011-05-05
GEMOXIAL
Assistance Publique - Hôpitaux de Paris
Phase 3
Terminated
263 enrolled